Followers | 372 |
Posts | 20769 |
Boards Moderated | 4 |
Alias Born | 04/08/2011 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 06, 2017 3:14:00 PM
V.NSP | 7 hours ago
(TheNewswire
VANCOUVER, British Columbia / TheNewswire / November 6, 2017 -- Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSX-V:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce that the Company expects to receive final approval from Japanese authorities to distribute CBD formulated capsules in Japan in short order.
Naturally Splendid CEO Mr. Dave Eto comments, “NSE has contributed significant work towards the application process to launch our first CBD infused products into the Japanese market through an e-commerce campaign being managed by First Step Japan (FSJ). FSJ is a marketing and distribution company located in Tokyo with extensive expertise in the Japanese consumer market. An initial order for the Japanese market has been placed in anticipation of final approval from the Japanese authorities. NSE’s Japanese specific website for this market will be activated immediately upon final approval”.
Furthermore, Naturally Splendid has received an update from Ambarri Corp regarding the sale and distribution of Ambarii’s proprietary mouth-melt full spectrum hemp CBD tablets (“Ambarii CBD Tablets”) to be marketed in Japan and South Korea under the NATERA® CBD brand. Initial samples incorporating Naturally Splendid’s HempOmega™ technology and Ambarii’s proprietary fast-acting and highly absorbant delivery mechanism are being provided for evaluation and testing.
Ambarii CBD Tablets are quick dissolving and offer a metered dose of full spectrum hemp oil, combined with the powerful antioxidant properties of pterostilbene. The tablets will be flavor variant with zero-sugar. Ambarii CBD Tablets represent a market first and the only commercially ready tablet of its kind. The incorporation of HempOmega™ into this already unique offering, and is differentiator when compared to products in the same category.
Ambarii, a joint venture between NeutriSci and Lexaria Bioscience Corp, was founded to develop and utilize the proprietary and patented technology of both Neutrisci and Lexaria. Lexaria, a drug delivery platform innovator, recently announced it has received a new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) for the use of its technology as a delivery platform for all cannabinoids including THC; fat soluble vitamins; non-steroidal anti-inflammatory pain medications (“NSAIDs”); and nicotine. The technology that Lexaria has recently received the Notice for Allowance from the USPTO, provides superior fast acting absorption which will be a significant differentiator for Japanese consumers looking for high quality products.
Naturally Splendid President Mr. Craig Goodwin states, “We remain confident that the products we have developed will have broad commercial appeal in Japan. We have gone through an extensive exercise to have our first CBD capsules approved for the Japanese market. And now we look forward to adding the Ambarri CBD Tablets to our on-line offerings. Naturally Splendid will continue to focus on hemp-derived Cannabidiol (CBD), the non-psychoactive cannabinoid as well as pursue additional opportunities to incorporate our HempOmega™ ingredient into the Ambarri formulations”.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.
Naturally Splendid currently has four innovative divisions:
(1) BIOTECHNOLOGY – Focused on three major platforms:
(1) Proprietary HempOmega™ encapsulation
(2) Extraction and formulation with Cannabidiol (CBD)
(3) Hemp and plant-based proteins.
- POS-BPC Facility - a 12,000-square-foot facility jointly operated by NSE 51% / 49% POS Holdings, offers commercial-scale custom processing solutions for functional foods and natural health.
(2) CONSUMER PRODUCTS -
- NATERA® - brand of retail hemp and superfood products distributed throughout North America, Asia and Europe.
- Prosnack Natural Foods Inc. (Elevate Me™) - lifestyle brand of heathy meal replacement products distributed throughout North America.
- Chi Hemp Industries Incorporated (CHII) - e-commerce platform for natural and organic hemp products.
- PawsitiveFX® - topical pet care products.
- NATERA®CBD - retail hemp-based cannabinoid nutraceutical and cosmeceutical products distributed in Asia.
- NATERA®Skincare - brand of retail hemp based cosmeceutical products.
(3) NATERA® Ingredients - bulk ingredients including HempOmega™.
(4) Co-Packaging/Toll-Processing - packaging for house-brands (NATERA® and CHII) and third-party partners.
For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573
On Behalf of the Board of Directors
Mr. Dave Eto
CEO, Director
Contact Information
Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
E-mail: info@naturallysplendid.com
Website: www.naturallysplendid.com
Read more at http://www.stockhouse.com/news/press-releases/2017/11/06/cbd-products-final-approval-for-japan-distribution-ambarii-corp-providing#iWUeJX4uSGpomJLK.99
Damn it feels good to be a gangster.
Recent LEXX News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/06/2024 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 07:28:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:59 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/16/2024 08:47:26 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:20:50 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 06:51:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 07:12:07 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/24/2024 06:33:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/18/2024 07:38:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 10:11:16 PM
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream • GlobeNewswire Inc. • 01/11/2024 01:30:00 PM
- Beyond Diabetes, a Blockbuster Horizon Beckons • InvestorsHub NewsWire • 01/10/2024 01:45:00 PM
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform • GlobeNewswire Inc. • 01/09/2024 01:30:00 PM
- Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs • InvestorsHub NewsWire • 01/08/2024 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:07:45 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/30/2023 09:14:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/20/2023 10:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 05:13:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 05:45:34 PM
- Get Ready for Next Generation of Diabetes, Weight-Management Drugs • InvestorsHub NewsWire • 11/01/2023 12:45:00 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM